Melanoma Clinical Trial
Prospective Matched Case-Control Study With AU-011 or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)
Summary
This is a prospective multicenter, matched case-control study of patients with primary indeterminate lesions or choroidal melanoma who receive treatment with AU-011 and patients who are planned to receive standard of care (SOC) treatment with plaque radiotherapy (plaque) to compare the visual outcomes of AU-011 and plaque radiotherapy.
Full Description
Up to approximately 45 patients who are planned to receive plaque radiotherapy for the treatment of IL/CM based on the expert judgment of the Investigator are planned to be enrolled.
Eligibility Criteria
Have per the investigator's expert clinical judgment, a clinical diagnosis of primary indeterminate lesion or choroidal melanoma based on the clinical history, ophthalmic examination, fundus photography and conventional ocular ultrasound.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 7 Locations for this study
Royal Oak Michigan, 48073, United States More Info
Principal Investigator
Portland Oregon, 97239, United States More Info
Principal Investigator
Greenville South Carolina, 29605, United States More Info
Principal Investigator
Nashville Tennessee, 37203, United States More Info
Principal Investigator
Bellaire Texas, 77401, United States More Info
Principal Investigator
Dallas Texas, 75231, United States More Info
Principal Investigator
Madison Wisconsin, 53705, United States More Info
Principal Investigator
How clear is this clinincal trial information?